4//SEC Filing
Baroldi Joseph 4
Accession 0000874015-25-000243
CIK 0000874015other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:35 PM ET
Size
9.4 KB
Accession
0000874015-25-000243
Insider Transaction Report
Form 4
Baroldi Joseph
EVP, Chief Business Officer
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-02−15,000→ 26,700 totalExercise: $31.80From: 2023-01-31Exp: 2032-01-30→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2025-10-02$31.80/sh+15,000$477,000→ 46,926 total - Sale
Common Stock
2025-10-02$68.01/sh−15,000$1,020,210→ 31,926 total
Holdings
- 3,071(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.07 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001813775
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:35 PM ET
- Size
- 9.4 KB